News for Mayne Pharma Group Limited (MYX.AX)

Australian shares are expected to open modestly up this Thursday morning, likely…

Good Afternoon and welcome to Market Close for Wednesday 4th of June 2025, I’m Jon Davidson. It was another good...

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets…

The ASX 200 closed up 0.52% at 8,386 points. Energy was the…

Asian stock markets are trading mostly higher on Wednesday, despite the broadly negative cues from Wall Street overnight, as some traders are still looking to cash in on the strong upside in the markets seen over the past several weeks.

Welcome to the halfway point of a busy Wednesday, with a lot happening on the market today. Here's the big headlines:

The ASX 200 has been up 0.85% at 8,415 points. Catalyst Metals…

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete

**media[598085]**

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NMYX.AX - Mayne Pharma Group LtdHalf Year 2025 Mayne Pharma Group Ltd Earnings CallFeb 25, 2025

The major U.S. index futures are currently pointing to a roughly flat open on Friday, with stocks likely to show a lack of direction following the weakness seen in the previous session.

Asian stock markets are trading mostly higher on Friday, despite the broadly negative from Wall Street overnight, as traders seemed cautious and await clarity on US President Donald Trump's trade policies and the outcome of Ukraine peace talks.

Mayne Pharma (ASX: MYX) has received a takeover offer at a price of $7.40 per share from US-based pharmaceutical company Cosette Pharma, valuing the

The ASX200 closed down 0.34% at 8,482 points. Investment manager Franklin Templeton…

Mayne Pharma (ASX: MYX) has reported a forecast revenue of between $210 million and $215m for the first half of the 2025 financial year, reflecting growth

Rising Prevalence of Chronic Pain Conditions and the Geriatric Population Drive Morphine Market Growth...

Revenue: Increased 112% to $388 million.Gross Margin: Expanded to 56.3%, a 24% improvement.Underlying EBITDA: $22.9 million, up $118.2 million from negative $9

The ASX200 broke its winning streak closing slightly down by point zero four of a percent at 8,024 points.

The ASX200 has been down 0.16% at 8,015 points. The market was lead lower by Wall Street as investors await an overnight speech by US Federal Reserve Chair, Jerome Powell.